Johnson & Johnson Receivables 2010-2024 | JNJ

Johnson & Johnson receivables for the quarter ending September 30, 2024 were $16.174B, a 9.3% increase year-over-year.

  • Johnson & Johnson receivables for 2023 were $14.873B, a 5.94% increase from 2022.
  • Johnson & Johnson receivables for 2022 were $14.039B, a 8.14% decline from 2021.
  • Johnson & Johnson receivables for 2021 were $15.283B, a 12.57% increase from 2020.

Johnson & Johnson Receivables 2010-2024 | JNJ

  • Johnson & Johnson receivables for 2023 were $14.873B, a 5.94% increase from 2022.
  • Johnson & Johnson receivables for 2022 were $14.039B, a 8.14% decline from 2021.
  • Johnson & Johnson receivables for 2021 were $15.283B, a 12.57% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B